Evolution and clinical significance of the T cell proliferative and cytokine response directed against the fibronectin binding antigen 85 complex of bacillus Calmette-Guerin during intravesical treatment of superficial bladder cancer.Alexandre R. Zlotta, Kris Huygen, Annie Drowart et al.|PubMed|1997Cited by 45
Evolution and Clinical Significance of the T Cell Proliferative and Cytokine Response Directed Against the Fibronectin Binding Antigen 85 Complex of Bacillus Calmette-Guerin During Intravesical Treatment of Superficial Bladder CancerAlexandre R. Zlotta, Kris Huygen, Michel de Cock et al.|The Journal of Urology|1997Cited by 39
SUPERFICIAL BLADDER TUMORS AND INCREASED REACTIVITY AGAINST MYCOBACTERIAL ANTIGENS BEFORE BACILLUS CALMETTE-GUERIN THERAPYAlexandre R. Zlotta, Kris Huygen, Annie Drowart et al.|The Journal of Urology|1998Cited by 10
Evolution and Clinical Significance of the T Cell Proliferative and Cytokine Response Directed Against the Fibronectin Binding Antigen 85 Complex of Bacillus Calmette-Guerin During Intravesical Treatment of Superficial Bladder CancerAlexandre R. Zlotta, Kris Huygen, Annie Drowart et al.|The Journal of Urology|1997Cited by 1
La nécessité d'un traitement prolongé par BCG dans les cancers superficiels de la vessie est suggérée par l'évolution de la réponse immunitaire périphérique induite par le BCGH Shekarsarai, Kris Huygen, Alexandre R. Zlotta et al.|Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles)|1997Cited by 0